S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom

In venue fit for head of state, Japan PM seeks Pfizer doses


People wearing protective masks to help curb the spread of the coronavirus walk along a pedestrian crossing Thursday, July 22, 2021, in Tokyo. The Japanese capital confirmed more than 1900 new coronavirus cases on Thursday. (AP Photo/Eugene Hoshiko)

TOKYO (AP) — Japan's prime minister met with Pfizer's CEO in an unusually high-profile setting Friday to make sure the drugmaker would deliver the COVID-19 vaccine as promised by this fall as the nation faces supply concerns and a growing outbreak.

Pfizer Inc. CEO Albert Bourla, who is in Tokyo to attend Friday's opening ceremony of the Olympics, was greeted by Prime Minister Yoshihide Suga at the Akasaka Palace state guest house, usually used to welcome heads of state. Suga’s special hospitality for Pfizer's leader comes as Japan is seeing its vaccination drive slow as local officials pressure the central government for speedier and stable deliveries.

During their nearly one-hour breakfast meeting, Suga explained Japan’s ongoing virus resurgence and vaccine status. Suga and Burla discussed a stable shipment of the vaccine, and Suga stressed that vaccines are the “trump card” in restoring social and economic activities, officials said.

Suga also thanked Burla for donating tens of thousands of doses of Pfizer vaccine for Olympic athletes and participants to ensure their health during the pandemic-delayed games, government officials said.

Taro Kono, a state minister in charge of vaccinations, joined the two at the state guest house, Japanese media reported.

Japan has signed with Pfizer to receive 100 million COVID-19 vaccine doses by June, and additional 70 million between July and September.

About 23% of its population of more than 126 million has been fully vaccinated, a number that has picked up since May but is still far short of where Japan’s government had hoped to be before the Olympics. Younger people are largely unvaccinated.

Suga asked Burla to push forward a delivery of 20 million doses planned for around October, Kyodo News reported, quoting unidentified officials.

Burla, who has Greek and Jewish background, thanked Suga for the warm hospitality and wished Japan a successful Olympics. Their meeting came the day after Olympic organizers dismissed the opening ceremony director over a joke he made about the Holocaust.


Japan has weathered the pandemic better than many other countries, logging about 853,000 cases and 15,100 deaths since the pandemic began. But infections have been surging, with Tokyo itself hitting a six-month high of 1,979 daily cases on Thursday.

Spectators are banned from all venues in the Tokyo area, with limited audiences allowed at a few outlying sites, in a step taken to try to curb the spread of the coronavirus. But Suga’s government has been criticized for what some say is prioritizing the Olympics over the nation’s health.

Should you invest $1,000 in Pfizer right now?

Before you consider Pfizer, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pfizer wasn't on the list.

While Pfizer currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Pfizer (PFE)
4.9926 of 5 stars
$25.41-1.1%6.61%70.57Hold$36.88
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

7 Stocks to Help You Build Off January’s Gains

7 Stocks to Help You Build Off January’s Gains

It's frequently said that as January goes, so goes the market. If that's the case, it's time for investors to put money to work in the stock market.

Search Headlines: